Fetal tissue banking: Standards and regulatory issues

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 2, 1996, Pages 189-193

  Newman Gage, Helen ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRAIN TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE AND PUBLIC HEALTH; HEALTH CARE FACILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEGAL ASPECT; PANCREAS ISLET TRANSPLANTATION; REVIEW; STANDARD; UNITED STATES; BRAIN CELL; CELL TRANSPLANTATION; CONFERENCE PAPER; HEALTH CARE POLICY; HEMATOPOIETIC STEM CELL; PANCREAS ISLET CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; TISSUE PRESERVATION;

HEALTH CARE AND PUBLIC HEALTH;

ADULT; BRAIN TISSUE TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; TISSUE BANKS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0030120209     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.189     Document Type: Article

References (16)

1. Strong, D.M., Newman-Gage, H., Moogk, M., et al. Impact of FDA regulation on a processor of human allograft heart valves. J. Transplant. Coordination 5:9, 1995.
2. Simonds, R.J., Holmberg, D.S., Hurwitz, R.L., et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med. 326:726, 1992.
3. Centers for Disease Control and Prevention. USPHS guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR 43(RR-8):1, 1994.
4. Rosenberg, S.A., Packard, B.S., Aebersold, P.M., et al. Use of tumor-infiltrating lymphocytes and interleukin 2 in the immunotherapy of patients with metastatic melanoma: A preliminary report. N. Engl. J. Med. 319:1676, 1988.
5. Food and Drug Administration, DHHS. Application of current statutory authorities to human somatic cell therapy products and gene therapy products: Notice. Federal Register 58(197):53248, 1993.
6. Vawter, D.E., Kearney, W., Gervais, K.G., et al. The Use of Human Fetal Tissue: Scientific, Ethical, and Policy Concerns. Center for Biomedical Ethics, University of Minnesota, Minneapolis, MN. 1990; Appendix B:B1.
7. NIH Guide. NIH interim guidelines for the support and conduct of therapeutic human fetal tissue transplantation research. N.I.H. Guide 22(11),March 1993.
8. National Institutes of Health Revitalization Act. Part II - Research on transplantation of Fetal Tissue. Public Law 103-43, June 10, 1993.
9. Food and Drug Administration, DHHS. Human tissue intended for transplantation: Interim rule (21 CFR Parts 16 et al.). Federal Register 58(238):65514, 1993.
10. Kessler, D.A., Siegel, J.P., Noguchi, P.D., et al. Regulation of somatic cell therapy and gene therapy by the Food and Drug Administration. N. Engl. J. Med. 329:1169, 1993.
11. Noguchi, P.D. Cell transplantation and federal regulation. Cell transplant. 4:411, 1995.
12. American Association of Blood Banks. Standards for Blood Banks and Transfusion Services, 15th ed. American Association of Blood Banks, Bethesda, MD, 1993.
13. American Association of Tissue Banks. Standards for Tissue Banking, 7th ed. American Association of Tissue Banks, McLean, VA, 1996.
14. Food and Drug Administration, DHHS Draft document: Concerning the regulation of placental/umbilical cord blood stem cell products intended for transplantation or further manufacturing into injectable products. Federal Register 61:7087, 1996.
15. Touraine, J.L. In utero transplantation of embryonic liver stem cells in humans. Blood Cells 17:379, 1991.
16. Touraine, J.L. The embryonic liver as a source of stem cells for transplantation into fetuses in utero. Curr. Top. Immunol. Microbiol. 177:187, 1992.